• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 and Hypercoagulable State: A New Therapeutic Perspective.

作者信息

Nascimento Jorge Henrique Paiter, Gomes Bruno Ferraz de Oliveira, Carmo Júnior Plínio Resende do, Petriz João Luiz Fernandes, Rizk Stephanie Itala, Costa Isabela Bispo Santos da Silva, Lacerda Marcus Vinicius Guimarães, Bacal Fernando, Hajjar Ludhmila Abrahão, Oliveira Gláucia Maria Moraes de

机构信息

Universidade Federal do Rio de Janeiro - Cardiologia,Rio de Janeiro, RJ - Brasil.

Rede D'Or São Luiz - CardiologiaRio de Janeiro, RJ - Brasil.

出版信息

Arq Bras Cardiol. 2020 Jun 1;114(5):829-833. doi: 10.36660/abc.20200308.

DOI:10.36660/abc.20200308
PMID:32491074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8386998/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8c/8386998/e6acc153c588/0066-782X-abc-114-05-0829-gf02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8c/8386998/427a6eeb68f0/0066-782X-abc-114-05-0829-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8c/8386998/259154504793/0066-782X-abc-114-05-0829-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8c/8386998/e960e93e9ea0/0066-782X-abc-114-05-0829-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8c/8386998/e6acc153c588/0066-782X-abc-114-05-0829-gf02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8c/8386998/427a6eeb68f0/0066-782X-abc-114-05-0829-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8c/8386998/259154504793/0066-782X-abc-114-05-0829-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8c/8386998/e960e93e9ea0/0066-782X-abc-114-05-0829-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8c/8386998/e6acc153c588/0066-782X-abc-114-05-0829-gf02-en.jpg

相似文献

1
COVID-19 and Hypercoagulable State: A New Therapeutic Perspective.COVID-19与高凝状态：一种新的治疗视角。
Arq Bras Cardiol. 2020 Jun 1;114(5):829-833. doi: 10.36660/abc.20200308.
2
Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19.了解新冠肺炎危重症患者止血障碍的病理生理学。
Intensive Care Med. 2020 Aug;46(8):1603-1606. doi: 10.1007/s00134-020-06088-1. Epub 2020 May 15.
3
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).新型冠状病毒肺炎与止血：来自意大利血栓形成与止血协会（SISET）的立场文件。
Blood Transfus. 2020 May;18(3):167-169. doi: 10.2450/2020.0083-20. Epub 2020 Apr 8.
4
2020 - Year of COVID-19.2020年——新冠疫情之年。
J Thromb Haemost. 2020 Sep;18(9):2081. doi: 10.1111/jth.15041.
5
Anticoagulation in COVID-19: DDI Perspective.COVID-19中的抗凝治疗：药物相互作用视角
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620959457. doi: 10.1177/1076029620959457.
6
Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia.凝血病、血栓栓塞并发症以及肝素在 COVID-19 肺炎中的应用。
J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):711-716. doi: 10.1016/j.jvsv.2020.05.018. Epub 2020 Jun 17.
7
Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?秋水仙碱作为一种古老的抗炎药物，对新冠病毒肺炎是否有效？
J Clin Pharmacol. 2020 Jul;60(7):828-829. doi: 10.1002/jcph.1645. Epub 2020 May 23.
8
The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.抗凝治疗对新冠病毒感染患者死亡率的影响。
Am J Cardiol. 2020 Nov 1;134:155-157. doi: 10.1016/j.amjcard.2020.08.005. Epub 2020 Aug 15.
9
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.将抗癌药物重新用于 COVID-19 引起的炎症、免疫功能障碍和凝血障碍。
Br J Cancer. 2020 Sep;123(5):694-697. doi: 10.1038/s41416-020-0948-x. Epub 2020 Jun 22.
10
Thromboinflammation in COVID-19 acute lung injury.新型冠状病毒肺炎急性肺损伤中的血栓炎症反应。
Paediatr Respir Rev. 2020 Sep;35:20-24. doi: 10.1016/j.prrv.2020.06.004. Epub 2020 Jun 11.

引用本文的文献

1
Development of venous thromboembolism and its impact on hospitalized adults with covid-19: rapid systematic review.静脉血栓栓塞的发生及其对新冠病毒肺炎住院成人患者的影响：快速系统评价
J Vasc Bras. 2025 Mar 14;24:e20240073. doi: 10.1590/1677-5449.202400732. eCollection 2025.
2
Liver and Inflammatory Biomarkers Are Related to High Mortality in Hospitalized Patients with COVID-19 in Brazilian Amazon Region.肝脏和炎症生物标志物与巴西亚马逊地区新冠肺炎住院患者的高死亡率相关。
Life (Basel). 2024 Jul 11;14(7):869. doi: 10.3390/life14070869.
3
The Clinical Impact of Cardiovascular Symptoms on Post-Acute COVID-19 Syndrome.

本文引用的文献

1
[Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].严重急性呼吸综合征与2019冠状病毒病的临床和病理特征比较
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jun 12;43(6):496-502. doi: 10.3760/cma.j.cn112147-20200311-00312.
2
[Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].7例危重型新型冠状病毒肺炎合并肢端缺血患者的临床及凝血特征
Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 28;41(0):E006. doi: 10.3760/cma.j.issn.0253-2727.2020.0006.
3
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
心血管症状对急性后新冠综合征的临床影响。
Arq Bras Cardiol. 2023 May;120(5):e20230282. doi: 10.36660/abc.20230282.
4
Systematic Reviews and Meta-Analyses: Lighthouses in the Data Storm from the COVID-19 Pandemic.系统评价与荟萃分析：新冠疫情数据风暴中的灯塔
Arq Bras Cardiol. 2022 Aug;119(2):280-281. doi: 10.36660/abc.20220442.
5
Impact of Metabolic Risk Factors on COVID-19 Clinical Outcomes: An Extensive Review.代谢危险因素对 COVID-19 临床结局的影响：一篇全面的综述。
Curr Cardiol Rev. 2022;18(6):e090522204452. doi: 10.2174/1573403X18666220509154236.
6
Do Admitted COVID-19-Positive Patients on Anticoagulation Therapy Have a Reduced Hospital Stay and Disease Severity?接受抗凝治疗的新冠病毒检测呈阳性的住院患者住院时间会缩短且疾病严重程度会降低吗？
Cureus. 2022 Mar 22;14(3):e23382. doi: 10.7759/cureus.23382. eCollection 2022 Mar.
7
Factors Associated With the Illness of Nursing Professionals Caused by COVID-19 in Three University Hospitals in Brazil.巴西三所大学医院中与新冠病毒导致护理专业人员患病相关的因素
Saf Health Work. 2022 Jun;13(2):255-260. doi: 10.1016/j.shaw.2022.03.001. Epub 2022 Mar 15.
8
Survival Analysis of COPD Patients in a 13-Year Nationwide Cohort Study of the Brazilian National Health System.巴西国家卫生系统13年全国队列研究中慢性阻塞性肺疾病患者的生存分析
Front Big Data. 2022 Feb 7;4:788268. doi: 10.3389/fdata.2021.788268. eCollection 2021.
9
COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.新型冠状病毒肺炎（COVID-19）对中枢及外周神经系统影响的临床病理证据。
Adv Exp Med Biol. 2021;1353:197-215. doi: 10.1007/978-3-030-85113-2_11.
10
Aortic and Renal Artery Thrombosis as the First Clinical Manifestation of COVID-19 in a Heart Transplant Recipient.主动脉和肾动脉血栓形成作为心脏移植受者中COVID-19的首发临床表现
Arq Bras Cardiol. 2021 Nov;117(5):1045-1047. doi: 10.36660/abc.20201210.
抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
4
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
5
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.113 例新冠肺炎死亡患者的临床特征：回顾性研究。
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.
6
Clinical observation and management of COVID-19 patients.新型冠状病毒肺炎患者的临床观察与管理。
Emerg Microbes Infect. 2020 Dec;9(1):687-690. doi: 10.1080/22221751.2020.1741327.
7
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
8
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
9
Coronavirus Disease 2019 (COVID-19) in Italy.意大利的2019冠状病毒病（COVID-19）。
JAMA. 2020 Apr 14;323(14):1335. doi: 10.1001/jama.2020.4344.
10
Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.意大利伦巴第大区新冠疫情期间的重症监护利用情况：应急响应中的早期经验与预测
JAMA. 2020 Apr 28;323(16):1545-1546. doi: 10.1001/jama.2020.4031.